Filing Details

Accession Number:
0000899243-23-001577
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-01-11 16:05:32
Reporting Period:
2023-01-09
Accepted Time:
2023-01-11 16:05:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1661998 Homology Medicines Inc. FIXX Pharmaceutical Preparations (2834) 473468154
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1916155 Paul Alloway C/O Homology Medicines, Inc.
One Patriots Park
Bedford MA 01730
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-01-09 3,090 $1.39 20,103 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the settlement of restricted stock units.
  2. The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $1.39 to $1.40. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote 2.